science
plus
.abes.fr
|
explorer
À propos de :
van Gilst Wiek H.
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
van Gilst Wiek H.
Van Gilst W.H.
van Gilst Wiek H
Van Gilst Wiek H.
VAN GILST W. H.
van Gilst W.H
Gilst Wiek H. van
van Gilst W.H.
personal mailbox
w.h.van.gilst@med.rug.nl
familyName
van Gilst
Van Gilst
VAN GILST
Gilst
Given name
W. H.
W.H.
Wiek H.
Wiek H
W.H
Wiek H. van
is
relates
of
http://hub.abes.fr/oup/periodical/ageing/2010/volume_39/issue_2/101093ageingafp256/authorship/6
http://hub.abes.fr/oup/periodical/cardiovascres/2002/volume_54/issue_2/101016s0008636302002894/authorship/5
http://hub.abes.fr/oup/periodical/cardiovascres/2003/volume_57/issue_2/101016s0008636302007046/authorship/9
http://hub.abes.fr/oup/periodical/eurheartj/2008/volume_29/issue_5/101093eurheartjehn026/authorship/11
http://hub.abes.fr/oup/periodical/eurheartj/2000/volume_21/issue_23/101053euhj20002248/authorship/9
http://hub.abes.fr/oup/periodical/eurheartj/2003/volume_24/issue_5/101016s0195668x02005262/authorship/2
http://hub.abes.fr/oup/periodical/ndt/2006/volume_21/issue_11/101093ndtgfl244/authorship/6
http://hub.abes.fr/oup/periodical/ajh/2005/volume_18/issue_3/101016jamjhyper200409015/authorship/7
http://hub.abes.fr/oup/periodical/eurheartj/2010/volume_31/issue_21/101093eurheartjehq304/authorship/14
http://hub.abes.fr/oup/periodical/cardiovascres/2003/volume_59/issue_4/101016s0008636303005200/authorship/8
http://hub.abes.fr/bmj/periodical/heart/2011/volume_97/issue_19/B35772F810392F84E053120B220A0936/authorship/8
http://hub.abes.fr/bmj/periodical/heart/2012/volume_98/issue_18/B3581274EB4274AAE053120B220A9FCA/authorship/10
http://hub.abes.fr/oup/periodical/eurheartj/2005/volume_26/issue_13/101093eurheartjehi253/authorship/7
http://hub.abes.fr/oup/periodical/eurheartj/2008/volume_29/issue_12/101093eurheartjehn205/authorship/8
http://hub.abes.fr/oup/periodical/cardiovascres/1997/volume_35/issue_3/101016s0008636397001739/authorship/10
http://hub.abes.fr/oup/periodical/europeanheartjournal/1988/volume_9/issue_7/101093eurheartj97795/authorship/1
http://hub.abes.fr/oup/periodical/eurheartj/2005/volume_26/issue_22/101093eurheartjehi454/authorship/3
http://hub.abes.fr/oup/periodical/eurheartj/2003/volume_24/issue_5/101016s0195668x02007005/authorship/10
http://hub.abes.fr/oup/periodical/eurheartj/2003/volume_24/issue_5/101016s0195668x02008230/authorship/14
http://hub.abes.fr/oup/periodical/cardiovascres/1997/volume_34/issue_3/101016s0008636397000813/authorship/7
http://hub.abes.fr/oup/periodical/cardiovascres/1998/volume_40/issue_1/101016s0008636398000996/authorship/4
http://hub.abes.fr/oup/periodical/cardiovascres/1999/volume_43/issue_1/101016s0008636399000905/authorship/2
http://hub.abes.fr/oup/periodical/eurheartj/1998/volume_19/issue_8/101053euhj19980874/authorship/2
http://hub.abes.fr/oup/periodical/eurheartj/2002/volume_23/issue_7/101053euhj20012820/authorship/12
http://hub.abes.fr/oup/periodical/eurheartj/2007/volume_28/issue_16/101093eurheartjehm177/authorship/10
http://hub.abes.fr/oup/periodical/cardiovascres/1995/volume_30/issue_3/101016s0008636395000585/authorship/3
http://hub.abes.fr/oup/periodical/cardiovascres/2010/volume_85/issue_4/101093cvrcvp374/authorship/8
http://hub.abes.fr/oup/periodical/cardiovascres/1999/volume_42/issue_2/101016s0008636399000450/authorship/8
http://hub.abes.fr/oup/periodical/cardiovascres/2006/volume_71/issue_3/101016jcardiores200604011/authorship/3
http://hub.abes.fr/oup/periodical/cardiovascres/2010/volume_87/issue_1/101093cvrcvq041/authorship/7
http://hub.abes.fr/oup/periodical/ajh/2007/volume_20/issue_10/101016jamjhyper200704023/authorship/5
http://hub.abes.fr/oup/periodical/ehj/2007/volume_28/issue_2/101093eurheartjehl419/authorship/8
http://hub.abes.fr/oup/periodical/eurheartj/2004/volume_25/issue_4/101016jehj200311017/authorship/4
http://hub.abes.fr/oup/periodical/cardiovascres/2009/volume_81/issue_2/101093cvrcvn337/authorship/4
http://hub.abes.fr/oup/periodical/eurheartj/2006/volume_27/issue_4/101093eurheartjehi603/authorship/5
http://hub.abes.fr/bmj/periodical/heart/2012/volume_98/issue_16/B3581274EB2374AAE053120B220A9FCA/authorship/9
is
Author
of
Differential localisation of the renin-angiotensin system in de-novo lesions and in-stent restenotic lesions in in-vivo human coronary arteries
Dyslipidemia and endothelium-dependent relaxation in internal mammary arteries used for coronary bypass surgery
Long-term follow-up after early intervention with intravenous diltiazem or intravenous nitroglycerin for unstable angina pectoris
Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation
Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients
Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study
A single dose of erythropoietin in ST-elevation myocardial infarction
Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 data
Renal Function Dependent Association of AGTR1 Polymorphism (A1166C) and Electrocardiographic Left-Ventricular Hypertrophy
Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure
Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial
Compliance in heart failure patients: the importance of knowledge and beliefs
Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy
Vectors based on Semliki Forest virus for rapid and efficient gene transfer into non-endothelial cardiovascular cells: comparison to adenovirus
Increased expression of cardiac angiotensin II type 1 (AT1) receptors decreases myocardial microvessel density after experimental myocardial infarction
Statins in the treatment of chronic heart failure: Biological and clinical considerations
Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well
Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study
Telomere biology in cardiovascular disease: the TERC−/− mouse as a model for heart failure and ageing
Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial
Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense? The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
The ACE gene polymorphism: the good, the bad and the ugly
The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe
Relation between myocardial β-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril
Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation
β-Adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy
Left atrial pressure reduction for mitral stenosis reverses left atrial direction-dependent conduction abnormalities
Telomere length and psychological well-being in patients with chronic heart failure
The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study
The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe
Serum potassium values in relation to the use of diuretics in patients with unstable angina pectoris
Erythropoietin in cardiovascular diseases
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
